SEC Filing

SEC Filing Details

Document Details

Form

Filing Date

Jan 11, 2021

Document Date

Jan 11, 2021

Form Description

EFFECT

Filing Group

Other

Company

BioLineRx

Issuer

BioLineRx Ltd.

Filing Formats

View HTML

Press Releases View all

December 16, 2020

BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)

November 23, 2020

BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update

November 18, 2020

BioLineRx to Report Third Quarter 2020 Results on November 23, 2020

Upcoming Events View all